A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

NCT07159763 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
7500
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)